Clinical Oncology - Issue Supplementum 1/2026
Editorial
Original Articles
6
Cancer screening programmes in the Czech Republic and their results
K. Hejcmanová, O. Ngo, R. Chloupková, M. Ambrožová, P. Dvořák, V. Rybenská, J. Daneš, Š. Suchánek, V. Dvořák, M. Koziar Vašáková, R. Zachoval, K. Hejduk, L. Dušek, O. Májek
Review
12
Polygenic risk score and its role in cancer susceptibility
A. Mišove, E. Macháčková, K. Nováková, M. Svoboda
17
Multicancer early detection (MCED) tests – an overview of technologies and clinical evidence
T. Büchler, M. Zubaľ, M. Svoboda, J. Halámková
26
Physical activity in cancer prevention
E. Sovová, M. Sovová
31
Nicotine products on the market and cancer risk
A. Pánková, K. Zvolská, E. Králíková
36
Impact of obesity on the development of malignant tumors – metabolic syndrome
L. Gescheidtová, Z. Čermáková
49
OncoVis: carcinogenic substances, their classification and potential impact on cancer development – an interactive dashboard for clinical practice
S. Skřídlová, M. Maliszewski, P. Gregor, A. Vrzalová, M. Průšová, M. Kuncová, P. Čupr
53
Disruption of hormonal balance and the potential development of cancer – the impact of endocrine disruptors
K. Hilscherová, Z. Toušová, P. Mikušová, V. Janečková
58
Microplastic in human body – a critical insight into current microplastic research
M. Vykypělová, V. Khrapova, O. Adamovský
67
Probiotics, postbiotics, and synbiotics in the prevention of oncological diseases
P. Bořilová Linhartová, D. Száraz
Clinical Oncology
2026 Issue Supplementum 1
Most read in this issue
- Nicotine products on the market and cancer risk
- OncoVis: carcinogenic substances, their classification and potential impact on cancer development – an interactive dashboard for clinical practice
- Cancer screening programmes in the Czech Republic and their results
- Polygenic risk score and its role in cancer susceptibility